$MYSZ
My Size, Inc. Stock $mysz

$mysz Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017439 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.290M	$720.0K	$400.0K
YoY Change	61.05%	80.0%	1233.33%
Cost Of Revenue	$771.0K	$1.147M	$250.0K
YoY Change	60.96%	358.8%
Gross Profit	$519.0K	-$427.0K	$38.00K
YoY Change	61.18%	-1223.68%	26.67%
Gross Profit Margin	40.23%	-59.31%	9.5%
Selling, General & Admin	$1.846M	$1.723M	$1.846M
YoY Change	16.54%	-6.66%	57.78%
% of Gross Profit	355.68%		4857.89%
Research & Development	$227.0K	$342.0K	$412.0K
YoY Change	-41.79%	-16.99%	11.35%
% of Gross Profit	43.74%		1084.21%
Depreciation & Amortization	$70.00K	$27.00K	$36.00K
YoY Change	75.0%	-25.0%	260.0%
% of Gross Profit	13.49%		94.74%
Operating Expenses	$2.073M	$2.065M	$2.258M
YoY Change	5.02%	-8.55%	46.62%
Operating Profit	-$1.554M	-$2.492M	-$2.105M
YoY Change	-5.93%	18.38%	39.4%
Interest Expense	$40.00K	-$180.0K	-$80.00K
YoY Change	-166.67%	125.0%	-233.33%
% of Operating Profit
Other Income/Expense, Net	$46.00K	-$146.0K	-$83.00K
YoY Change	-171.88%	75.9%
Pretax Income	-$1.513M	-$2.672M	-$2.188M
YoY Change	-11.83%	22.12%	49.86%
Income Tax	-$222.0K	-$18.00K
% Of Pretax Income
Net Earnings	-$1.291M	-$2.654M	-$2.188M
YoY Change	-24.77%	21.3%	49.86%
Net Earnings / Revenue	-100.08%	-368.61%	-547.0%
Basic Earnings Per Share	$0.53	-$1.68	-$2.25
Diluted Earnings Per Share	$0.53	-$1.68	-$2.21
COMMON SHARES
Basic Shares Outstanding	2.447M shares	2.447M shares	501.8K shares
Diluted Shares Outstanding	2.444M shares	197.8K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.130M	$2.420M	$7.840M
YoY Change	-82.51%	-69.13%	36.11%
Cash & Equivalents	$1.127M	$2.415M	$8.112M
Short-Term Investments
Other Short-Term Assets	$120.0K	$260.0K	$270.0K
YoY Change	-53.85%	-3.7%	0.0%
Inventory	$1.043M	$491.0K	$1.100M
Prepaid Expenses
Receivables	$754.0K	$1.008M	$130.0K
Other Receivables	$950.0K	$780.0K	$1.200M
Total Short-Term Assets	$3.992M	$4.953M	$10.54M
YoY Change	-56.03%	-53.01%	65.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$130.0K	$107.0K	$990.0K
YoY Change	-15.03%	-89.19%	4.21%
Goodwill	$1.403M	$1.412M
YoY Change	423.51%
Intangibles	$1.228M	$1.313M
YoY Change	276.69%
Long-Term Investments	$80.00K	$100.0K	$90.00K
YoY Change	-20.0%	11.11%	-18.18%
Other Assets	$30.00K	$30.00K	$30.00K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$3.302M	$3.515M	$1.740M
YoY Change	107.93%	102.01%	64.15%
TOTAL ASSETS
Total Short-Term Assets	$3.992M	$4.953M	$10.54M
Total Long-Term Assets	$3.302M	$3.515M	$1.740M
Total Assets	$7.294M	$8.468M	$12.28M
YoY Change	-31.61%	-31.04%	65.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.530M	$1.770M	$1.840M
YoY Change	-16.39%	-3.8%	166.67%
Accrued Expenses	$150.0K	$160.0K	$180.0K
YoY Change	-11.76%	-11.11%	50.0%
Deferred Revenue
YoY Change
Short-Term Debt	$152.0K	$158.0K	$230.0K
YoY Change	-15.56%	-31.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.107M	$2.851M	$2.250M
YoY Change	30.44%	26.71%	174.39%
LONG-TERM LIABILITIES
Long-Term Debt	$306.0K	$342.0K	$140.0K
YoY Change	215.46%	144.29%
Other Long-Term Liabilities	$200.0K	$300.0K	$510.0K
YoY Change	-52.38%	-41.18%	-3.77%
Total Long-Term Liabilities	$754.0K	$955.0K	$650.0K
YoY Change	28.01%	46.92%	22.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.107M	$2.851M	$2.250M
Total Long-Term Liabilities	$754.0K	$955.0K	$650.0K
Total Liabilities	$3.861M	$3.806M	$2.980M
YoY Change	29.96%	27.72%	120.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$57.45M	-$56.16M
YoY Change	17.01%
Common Stock	$2.000K	$2.000K
YoY Change	-92.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.433M	$4.662M	$9.298M
YoY Change
Total Liabilities & Shareholders Equity	$7.294M	$8.468M	$12.28M
YoY Change	-31.61%	-31.04%	65.05%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.291M	-$2.654M	-$2.188M
YoY Change	-24.77%	21.3%	49.86%
Depreciation, Depletion And Amortization	$70.00K	$27.00K	$36.00K
YoY Change	75.0%	-25.0%	260.0%
Cash From Operating Activities	-$1.330M	-$2.313M	-$2.579M
YoY Change	-10.74%	-10.31%	103.07%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$21.00K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$300.0K
YoY Change		-100.0%
Cash From Investing Activities	$0.00		-$321.0K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	$2.634M	$7.000K
YoY Change	0.0%	37528.57%	-99.87%
NET CHANGE
Cash From Operating Activities	-1.330M	-$2.313M	-$2.579M
Cash From Investing Activities	0.000		-$321.0K
Cash From Financing Activities	-30.00K	$2.634M	$7.000K
Net Change In Cash	-1.360M	$313.0K	-$2.831M
YoY Change	-11.11%	-111.06%	-169.05%
FREE CASH FLOW
Cash From Operating Activities	-$1.330M	-$2.313M	-$2.579M
Capital Expenditures	$0.00		$21.00K
Free Cash Flow	-$1.330M	-$2.313M	-$2.600M
YoY Change	-11.33%	-11.04%	104.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001211805
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	mysz	Increase Decrease In Investment In Joint Venture IncreaseDecreaseInInvestmentInJointVenture		usd
CY2023Q1	mysz	Restricted Shares Issued To Shareholders RestrictedSharesIssuedToShareholders		usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2023Q1	mysz	Noncash Or Part Noncash Acquisition Issuance Of Shares NoncashOrPartNoncashAcquisitionIssuanceOfShares		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37370
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MY SIZE, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0394637
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	HaYarden 4
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	POB 1026
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Airport City
CY2023Q1	dei	Entity Address Country EntityAddressCountry	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	7010000
CY2023Q1	dei	City Area Code CityAreaCode	972
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	3-600-9030
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	MYSZ
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2446780	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2415000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	261000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	263000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	491000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	997000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1008000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1940000	usd
CY2023Q1	mysz	Other Receivables And Prepaid Expenses Current OtherReceivablesAndPrepaidExpensesCurrent	778000	usd
CY2022Q4	mysz	Other Receivables And Prepaid Expenses Current OtherReceivablesAndPrepaidExpensesCurrent	758000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4953000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6058000	usd
CY2023Q1	us-gaap	Deposit Assets DepositAssets	28000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	28000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	140000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	557000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	583000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1313000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1377000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1412000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1395000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	65000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	99000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	33000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	47000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	3515000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3669000	usd
CY2023Q1	us-gaap	Assets Assets	8468000	usd
CY2022Q4	us-gaap	Assets Assets	9727000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	155000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	158000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	155000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1766000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2487000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	675000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	698000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2105000	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	97000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	680000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2851000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4179000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	342000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	376000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	313000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	328000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	300000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	308000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	955000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1012000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3806000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5191000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2446780	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2446780	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1464117	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1464117	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61467000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58673000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-652000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-637000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56155000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53501000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4662000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4536000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8468000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9727000	usd
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:25 reverse stock split
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	720000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1147000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-427000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	38000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	342000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	412000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	679000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	959000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1044000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	887000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2065000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2258000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2492000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-146000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-83000	usd
CY2023Q1	mysz	Equity Income Of Equity Method Investees EquityIncomeOfEquityMethodInvestees	-34000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2672000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2188000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2654000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2188000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-15000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	58000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2669000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2130000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.68
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.25
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1582348	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	501841	shares
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	643000	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:25 reverse stock split
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4536000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	101000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	35000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	341000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2658000	usd
CY2023Q1	mysz	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	1000	usd
CY2023Q1	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-2669000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4662000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10857000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	114000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	457000	usd
CY2022Q1	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-2072000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9356000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10857000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10857000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	455000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1446000	usd
CY2022	mysz	Stock Issued During Period Value Acquisitions One StockIssuedDuringPeriodValueAcquisitionsOne	319000	usd
CY2022	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-8541000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4536000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4536000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2654000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2188000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	27000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	36000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	31000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	11000	usd
CY2023Q1	mysz	Amortization Of Intangible Asset AmortizationOfIntangibleAsset	74000	usd
CY2022Q1	mysz	Amortization Of Intangible Asset AmortizationOfIntangibleAsset	21000	usd
CY2022Q1	mysz	Change In Warrants And Derivatives ChangeInWarrantsAndDerivatives	1000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-23000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	72000	usd
CY2023Q1	mysz	Interest On Long Term Liabilities InterestOnLongTermLiabilities	6000	usd
CY2022Q1	mysz	Interest On Long Term Liabilities InterestOnLongTermLiabilities	45000	usd
CY2023Q1	mysz	Interest Paid Net Value InterestPaidNetValue	6000	usd
CY2022Q1	mysz	Interest Paid Net Value InterestPaidNetValue	4000	usd
CY2023Q1	mysz	Revaluation Of Investment In Marketable Securities RevaluationOfInvestmentInMarketableSecurities	-14000	usd
CY2022Q1	mysz	Revaluation Of Investment In Marketable Securities RevaluationOfInvestmentInMarketableSecurities	-14000	usd
CY2023Q1	mysz	Increase Decrease In Investment In Joint Venture IncreaseDecreaseInInvestmentInJointVenture	34000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	136000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	114000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-481000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	223000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-18000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-5000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-903000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-37000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	30000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	391000	usd
CY2023Q1	mysz	Increase Decrease In Trade Payable IncreaseDecreaseInTradePayable	-1403000	usd
CY2022Q1	mysz	Increase Decrease In Trade Payable IncreaseDecreaseInTradePayable	-178000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	152000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	91000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2313000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2579000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	300000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-321000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2659000	usd
CY2022Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	18000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	11000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2634000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-8000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	62000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	313000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2831000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2363000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10943000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2676000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8112000	usd
CY2022Q1	mysz	Noncash Or Part Noncash Acquisition Issuance Of Shares NoncashOrPartNoncashAcquisitionIssuanceOfShares	457000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6311000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56155000	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	14000	usd
CY2022Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	14000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	136000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	114000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	720000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2492000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4459000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-8110000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-017439-index-headers.html	Edgar Link	pending
0001493152-23-017439-index.html	Edgar Link	pending
0001493152-23-017439.txt	Edgar Link	pending
0001493152-23-017439-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mysz-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
mysz-20230331_cal.xml	Edgar Link	unprocessable
mysz-20230331_def.xml	Edgar Link	unprocessable
mysz-20230331_lab.xml	Edgar Link	unprocessable
mysz-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MYSZ
My Size, Inc. Stock $mysz

2023 Q2 Form 10-Q Financial Statement

#000149315223017439 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYSZ My Size, Inc. Stock $mysz

2023 Q2 Form 10-Q Financial Statement

#000149315223017439 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYSZ
My Size, Inc. Stock $mysz